Skip to Main Content

Paper Details

The risk of sudden cardiac arrest and ventricular arrhythmia with rosiglitazone versus pioglitazone: real-world evidence on thiazolidinedione safety.
Cardiovasc Diabetol
12
2020
Author NameAffiliation
Joshua J GagneDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Harvard University
Stephen E KimmelCenter for Pharmacoepidemiology Research and Training, Perelman School of Medicine, University of Pennsylvania
Stephen E KimmelPerelman School of Medicine, University of Pennsylvania
  • 1 - 3

Datasets